241 related articles for article (PubMed ID: 23856053)
1. Ion mobility-mass spectrometry of intact protein--ligand complexes for pharmaceutical drug discovery and development.
Niu S; Rabuck JN; Ruotolo BT
Curr Opin Chem Biol; 2013 Oct; 17(5):809-17. PubMed ID: 23856053
[TBL] [Abstract][Full Text] [Related]
2. Surface induced dissociation: dissecting noncovalent protein complexes in the gas phase.
Zhou M; Wysocki VH
Acc Chem Res; 2014 Apr; 47(4):1010-8. PubMed ID: 24524650
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry based tools to investigate protein-ligand interactions for drug discovery.
Pacholarz KJ; Garlish RA; Taylor RJ; Barran PE
Chem Soc Rev; 2012 Jun; 41(11):4335-55. PubMed ID: 22532017
[TBL] [Abstract][Full Text] [Related]
4. Investigation of protein-ligand interactions by mass spectrometry.
Sinz A
ChemMedChem; 2007 Apr; 2(4):425-31. PubMed ID: 17299828
[TBL] [Abstract][Full Text] [Related]
5. Ion mobility-mass spectrometry as a tool to investigate protein-ligand interactions.
Göth M; Pagel K
Anal Bioanal Chem; 2017 Jul; 409(18):4305-4310. PubMed ID: 28500372
[TBL] [Abstract][Full Text] [Related]
6. Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes.
Stojko J; Fieulaine S; Petiot-Bécard S; Van Dorsselaer A; Meinnel T; Giglione C; Cianférani S
Analyst; 2015 Nov; 140(21):7234-45. PubMed ID: 26401526
[TBL] [Abstract][Full Text] [Related]
7. Sizing Up Protein-Ligand Complexes: The Rise of Structural Mass Spectrometry Approaches in the Pharmaceutical Sciences.
Eschweiler JD; Kerr R; Rabuck-Gibbons J; Ruotolo BT
Annu Rev Anal Chem (Palo Alto Calif); 2017 Jun; 10(1):25-44. PubMed ID: 28301749
[TBL] [Abstract][Full Text] [Related]
8. Ion mobility mass spectrometry of proteins and protein assemblies.
Uetrecht C; Rose RJ; van Duijn E; Lorenzen K; Heck AJ
Chem Soc Rev; 2010 May; 39(5):1633-55. PubMed ID: 20419213
[TBL] [Abstract][Full Text] [Related]
9. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
10. Structurally selective imaging mass spectrometry by imaging ion mobility-mass spectrometry.
McLean JA; Fenn LS; Enders JR
Methods Mol Biol; 2010; 656():363-83. PubMed ID: 20680602
[TBL] [Abstract][Full Text] [Related]
11. Characterization of protein therapeutics by mass spectrometry: recent developments and future directions.
Chen G; Warrack BM; Goodenough AK; Wei H; Wang-Iverson DB; Tymiak AA
Drug Discov Today; 2011 Jan; 16(1-2):58-64. PubMed ID: 21093608
[TBL] [Abstract][Full Text] [Related]
12. Alternate dissociation pathways identified in charge-reduced protein complex ions.
Pagel K; Hyung SJ; Ruotolo BT; Robinson CV
Anal Chem; 2010 Jun; 82(12):5363-72. PubMed ID: 20481443
[TBL] [Abstract][Full Text] [Related]
13. Protein-nucleic acid complexes and the role of mass spectrometry in their structure determination.
Park AY; Robinson CV
Crit Rev Biochem Mol Biol; 2011 Apr; 46(2):152-64. PubMed ID: 21417597
[TBL] [Abstract][Full Text] [Related]
14. Application of the Exactive Plus EMR for automated protein-ligand screening by non-covalent mass spectrometry.
Maple HJ; Scheibner O; Baumert M; Allen M; Taylor RJ; Garlish RA; Bromirski M; Burnley RJ
Rapid Commun Mass Spectrom; 2014 Jul; 28(13):1561-8. PubMed ID: 24861608
[TBL] [Abstract][Full Text] [Related]
15. How useful is ion mobility mass spectrometry for structural biology? The relationship between protein crystal structures and their collision cross sections in the gas phase.
Jurneczko E; Barran PE
Analyst; 2011 Jan; 136(1):20-8. PubMed ID: 20820495
[TBL] [Abstract][Full Text] [Related]
16. Understanding protein-drug interactions using ion mobility-mass spectrometry.
Eyers CE; Vonderach M; Ferries S; Jeacock K; Eyers PA
Curr Opin Chem Biol; 2018 Feb; 42():167-176. PubMed ID: 29331721
[TBL] [Abstract][Full Text] [Related]
17. Studying noncovalent protein complexes by electrospray ionization mass spectrometry.
Loo JA
Mass Spectrom Rev; 1997; 16(1):1-23. PubMed ID: 9414489
[TBL] [Abstract][Full Text] [Related]
18. Native MS: an 'ESI' way to support structure- and fragment-based drug discovery.
Vivat Hannah V; Atmanene C; Zeyer D; Van Dorsselaer A; Sanglier-Cianférani S
Future Med Chem; 2010 Jan; 2(1):35-50. PubMed ID: 21426045
[TBL] [Abstract][Full Text] [Related]
19. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
Liu ZY
J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry supported determination of protein complex structure.
Walzthoeni T; Leitner A; Stengel F; Aebersold R
Curr Opin Struct Biol; 2013 Apr; 23(2):252-60. PubMed ID: 23522702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
